Paper published in a journal (Scientific congresses and symposiums)
Maintenance With Everolimus (RAD001) and Trastuzumab After Discontinuation of Chemotherapy in Heavily Pretreated HER-2+Metastatic Breast Cancer Patients: Pooled Data of Extension Cohorts of Phase Ib/II Studies
JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Fasolo, Angelica; Instituto Nazionale dei Tumori, Milan
Massacesi, Cristian; Novartis oncology
Balaisius, Megan; Novartis oncology
Manlius, Corinne; Novartis Pharma
Sahmoud, Tarek; Novartis oncology
Andre, Fabrice; Institut Gustave Roussy - IGR
Gianni, Luca; Instituto Nazionale dei Tumori, Milan
Language :
English
Title :
Maintenance With Everolimus (RAD001) and Trastuzumab After Discontinuation of Chemotherapy in Heavily Pretreated HER-2+Metastatic Breast Cancer Patients: Pooled Data of Extension Cohorts of Phase Ib/II Studies
Publication date :
2010
Event name :
2010 ASCO Annual Meeting
Event organizer :
ASCO
Event place :
Chicago, United States
Event date :
du 04 au 08 juin 2010
Audience :
International
Journal title :
Journal of Clinical Oncology
ISSN :
0732-183X
eISSN :
1527-7755
Publisher :
American Society of Clinical Oncology, Alexandria, United States - Virginia
